Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 11 and under 16 years old
- People with a BMI above 30 kg/m² or at or above the 95th percentile for BMI (a measure used to assess body weight relative to height and age)
- People at a mid-stage of puberty development, known as Tanner stage 2, 3, or 4 (confirm with trial site for clarification on what stage applies)
Who may not be able to join:
- People at the earliest or latest stage of puberty development (Tanner stage 1 or 5)
- People who have previously had weight-loss (bariatric) surgery
- People who have used certain weight-loss medications in the last 3 months, including orlistat, metformin, phentermine, topiramate, liraglutide, or a combination of naltrexone/bupropion (note: taking naltrexone or bupropion alone does not disqualify someone)
- People whose obesity is caused by a specific genetic condition or a problem with a part of the brain called the hypothalamus
- People who have been diagnosed by a doctor with polycystic ovary syndrome (PCOS)
- People who are pregnant or planning to become pregnant
- People currently using supplemental hormones
- People who have been diagnosed with an eating disorder such as anorexia nervosa, bulimia, or binge eating disorder
- People who have Type 1 or Type 2 diabetes
- People currently being treated with growth hormones
- People with a thyroid condition or problem
- People who have had cancer within the last 10 years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Justin Ryder, PhD, Ann & Robert H Lurie Children's Hospital of Chicago
Phone: 3148826838
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in fat mass regain after initial weight loss with meal replacement therapy (MRT); Change in ghrelin; Change in gastric inhibitory polypeptide
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.